金達威(002626.SZ):美國子公司DRB擬約1720萬美元購買Activ 100%股份
格隆匯2月4日丨金達威(002626.SZ)公佈,公司美國子公司Doctor's Best Inc.(以下簡稱DRB)於近日與美國Viactiv Nutritionals,Inc.(以下簡稱Viactiv)、Activ Nutritional, LLC(以下簡稱Activ或標的公司)及Guardion Health Sciences,Inc(Viactiv 母公司,簡稱 Guardion)簽訂《股權購買協議》。協議約定,DRB以現金方式向Viactiv購買其持有的Activ100%股份權益。本次交易對價約為1720萬美元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.